Cenicriviroc 150 mg ( DrugBank: Cenicriviroc )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
94原発性硬化性胆管炎1

94. 原発性硬化性胆管炎


臨床試験数 : 148 薬物数 : 118 - (DrugBank : 39) / 標的遺伝子数 : 18 - 標的パスウェイ数 : 141
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02653625
(ClinicalTrials.gov)
March 14, 20168/1/2016PERSEUS: Preliminary Efficacy and Safety of Cenicriviroc in Adult Participants With Primary Sclerosing CholangitisPERSEUS: A Phase 2 Proof of Concept Study Investigating the Preliminary Efficacy and Safety of Cenicriviroc in Adult Subjects With Primary Sclerosing Cholangitis (PSC)Primary Sclerosing CholangitisDrug: Cenicriviroc 150 mgTobira Therapeutics, Inc.NULLCompleted18 Years75 YearsAll24Phase 2United States;Canada